These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. 4-Methylumbelliferyl-beta-glucosidase in cultured human fibroblasts from controls and patients with Gaucher's disease. Hultberg B, Sjöblad S, Ockerman PA. Clin Chim Acta; 1973 Nov 23; 49(1):93-7. PubMed ID: 4764343 [No Abstract] [Full Text] [Related]
50. Multiple forms of human skin fibroblast beta-glucosidase and their activation by fibroblast monosialoglycosphingolipids. Saito M, Mueller OT, Rosenberg A. Prog Clin Biol Res; 1982 Nov 23; 95():385-403. PubMed ID: 6812078 [No Abstract] [Full Text] [Related]
51. Prenatal diagnosis of Gaucher disease. Assay of the beta-glucosidase activity in amniotic fluid cells cultivated in two laboratories with different cultivation conditions. Svennerholm L, Håkansson G, Lindsten J, Wahlström J, Dreborg S. Clin Genet; 1981 Jan 23; 19(1):16-22. PubMed ID: 6780254 [Abstract] [Full Text] [Related]
52. [Gaucher's disease (type 1) with clinical picture like a myelodysplastic syndrome: the difference between this Gaucher's cell and CML pseudo-Gaucher's cell]. Saito H, Uemura K, Maruyama T, Kawakami H, Iijima Y, Kitano K, Kaji R, Furuta S. Rinsho Ketsueki; 1987 Aug 23; 28(8):1449-55. PubMed ID: 3123742 [No Abstract] [Full Text] [Related]
53. Effectors of three beta-glucosidases from human liver. Daniels LB, Gnarra JR, Glew RH. Prog Clin Biol Res; 1982 Aug 23; 95():333-55. PubMed ID: 6812077 [Abstract] [Full Text] [Related]
54. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside. Choy FY, Bouillon L, Laurin CA. Am J Med Genet; 1987 Aug 23; 27(4):895-905. PubMed ID: 3425599 [Abstract] [Full Text] [Related]
55. Genetic heterogeneity in type I Gaucher disease. Devine EA, Beighton P, Petersen EM, Desnick RJ. Prog Clin Biol Res; 1982 Aug 23; 95():495-510. PubMed ID: 6812084 [Abstract] [Full Text] [Related]
56. Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease. Gatt S, Dinur T, Desnick RJ. Prog Clin Biol Res; 1982 Aug 23; 95():315-31. PubMed ID: 6812076 [No Abstract] [Full Text] [Related]
57. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease. Glew RH, Daniels LB, Clark LS, Hoyer SW. J Neuropathol Exp Neurol; 1982 Nov 23; 41(6):630-41. PubMed ID: 6813430 [Abstract] [Full Text] [Related]
58. Infantile Gaucher's disease: glucocerebrosidase deficiency in peripheral blood leukocytes and cultured fibroblasts. Sengers RC, Lamers KJ, Bakkeren JA, Schretlen ED, Trijbels JM. Neuropadiatrie; 1975 Nov 23; 6(4):377-82. PubMed ID: 241947 [Abstract] [Full Text] [Related]
59. Gaucher's disease in the Cape coloured population of the RSA, including a family with 5 affected siblings. Swart AL, Hesseling PB, Hayden MR, Louw M, Herbert JS. S Afr Med J; 1987 Jan 24; 71(2):97-9. PubMed ID: 3101207 [Abstract] [Full Text] [Related]
60. The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside. Broadhead DM, Butterworth J. Clin Chim Acta; 1977 Feb 15; 75(1):155-61. PubMed ID: 14796 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]